Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

CAR-T Meeting 2026

The EBMT-EHA 8th European CAR T-cell Meeting

12–14 February 2026 | Palma de Mallorca, Spain

Jointly organized by the EBMT and EHA, the 8th European CAR T-cell Meeting took place on February 12-14, 2026, in Palma de Mallorca, Spain, and online, and covered the latest clinical and translational advances in CAR T-cell therapy.

View all videos

The potential role of CAR T-cell therapy in acquired hemophilia A

Felicitas Thol • 17 Feb 2026

The current status of CAR T-cell therapy in CLL

Maria-Luisa Schubert • 27 Feb 2026

Quality of life in patients after CAR T-cell therapy

Mercedes Montoro-Lorite • 19 Feb 2026

The future of CAR T-cell therapy for B-ALL: multi-infusion strategies, MRD-guided approaches & more

Valentín Ortiz-Maldonado • 17 Feb 2026

The current status of CAR T-cell therapy in CLL

Maria-Luisa Schubert • 27 Feb 2026

The future of CAR T-cell therapy for B-ALL: multi-infusion strategies, MRD-guided approaches & more

Valentín Ortiz-Maldonado • 17 Feb 2026

The value of rapid and reliable manufacturing in the CAR-T process

Leyre Bento De Miguel • 16 Feb 2026

Comparing clinical trial data and real-world evidence to inform CAR T-cell therapy in DLBCL

Leyre Bento De Miguel • 16 Feb 2026

Quality of life in patients after CAR T-cell therapy

Mercedes Montoro-Lorite • 19 Feb 2026

The evolving role of nurses in the rapidly expanding field of CAR T-cell therapy

Erik Aerts • 14 Feb 2026

Results of the Phase II CART19-BE-02 trial of var-cel (ARI-0001) in patients with R/R B-ALL

Valentín Ortiz-Maldonado • 17 Feb 2026

Zamtocabtagene autoleucel, a tandem CD20-CD19 CAR, in R/R LBCL: data from the DALY 2-EU study

Gloria Iacoboni • 20 Feb 2026